Lighthouse Pharmaceuticals Announces Progression of LHP588 Clinical Development Program in Alzheimer's Disease

-  Pre-IND meeting related to Phase 2b SPRING trial completed with US FDA  -  World-class clinical advisory board to support clinical development ...

Related Keywords

Nevada ,United States ,California ,Las Vegas ,University Of Southern California ,San Francisco ,United Kingdom ,University Of Nevada Las Vegas ,Clive Holmes ,Michael Detke ,Lon Schneider ,Casey Lynch ,Jeffrey Cummings ,Mark Ryder ,Merce Boada ,Marwan Sabbagh ,Scientific Committee Of The Mediterranean Alzheimer Alliance ,Lighthouse Pharmaceuticals ,University Of Southampton ,University Of California ,Committee Of The European Alzheimer Disease Consortium ,Cleveland Clinic Lou Ruvo Center ,California Alzheimer Disease Center ,Cummings Is Research Professor ,Old Age Psychiatry At Southern Health Foundation ,Grundy Center ,Alzheimer Disease Research Center ,Alzheimer Disease Research ,Drug Administration ,Geriatric Studies Center ,Foundation Alzheimer Educational Centre ,Barrow Neurological Institute ,Marys Easton Center ,Brain Health In Las Vegas ,Prnewswire Lighthouse Pharmaceuticals ,Pre Investigational New Drug ,Clinical Advisory Board ,Lighthouse Pharma ,Chief Medical Officer ,Behavioral Neurologist ,Clinical Advisory ,Chief Executive Officer ,Clinical Advisory Board Members ,Cleveland Clinic Lou Ruvo ,Alzheimer Educational Centre ,Executive Committee ,European Alzheimer ,Disease Consortium ,Scientific Committee ,Mediterranean Alzheimer Alliance ,Research Professor ,Brain Health ,Nevada Las Vegas ,Chambers Grundy Center ,Disease Research ,Professor Emeritus ,Biological Psychiatry ,Old Age Psychiatry ,Southern Health Foundation ,Keck School ,California Alzheimer ,Disease Center ,